Metabolic Health 

For years, we have tended to think about metabolic disease through one main lens: blood sugar. If glucose is too high, we lower it. If HbA1c improves, the treatment is working. But obesity is much more complicated than that. Someone can live with significant obesity without having diabetes. They can have insulin resistance, fatty liver disease, high blood pressure, sleep apnoea and increased cardiovascular risk while their blood glucose still looks relatively normal. So perh

GLP-1 medications such as semaglutide (Wegovy®) and tirzepatide (Mounjaro®) have transformed obesity treatment, helping many people achieve significant and sustained weight loss for the first time. But one question comes up in almost every time I discuss this topic: “What happens when I stop taking it?” The short answer is that it depends—but for many people, weight regain is common. That doesn’t mean the medication has “failed”, nor does it mean you’ve done anything wrong. I

Carbohydrates (CHO) are a fundamental energy source, supporting cellular function, physical activity, and metabolic processes. However, a growing body of research suggests that chronically elevated carbohydrate metabolism—particularly in the context of sustained high glucose availability—can influence key biological pathways linked to aging. One central mechanism involves mitochondrial function and oxidative stress. During carbohydrate metabolism, glucose is processed through